FDA working to address injectable iron dextran shortage

Article

Washington -- The U.S. Food and Drug Administration's Center for Veterinary Medicine is working with an injectable iron dextran supplier to try and relieve a shortage of the drug.

Washington

-- The U.S. Food and Drug Administration's Center for Veterinary Medicine is working with an injectable iron dextran supplier to try and relieve a shortage of the drug.

The drug, which is used for the prevention and treatment of iron deficiency in baby pigs, is considered medically necessary by FDA. FDA says a shortage of the drug could "result in indue suffering and disruption in the swine industry."

To help the supplier, Bimedia Inc., address the shortage, FDA says the company may temporarily import and distribute injectable 200 mg/ml iron dextran product into the United States from its Canadian branch in Ontario through February 2011, or until an adequate U.S. supply is available.

Recent Videos
062018_cyberbullying-220_kjames.png
big-hand-cutting-the-wire-450px-shutterstock-568795309.jpg
Related Content
© 2024 MJH Life Sciences

All rights reserved.